Literature DB >> 14513249

[Mycophenolate mofetil as effective therapy option in scarring pemphigoid].

I Elser1, D Selimovic, T Ruzicka, A Kuhn, M Megahed.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513249     DOI: 10.1007/s00105-003-0595-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  22 in total

1.  Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230.

Authors:  M Leverkus; K Bhol; Y Hirako; H Pas; C Sitaru; G Baier; E B Bröcker; M F Jonkman; A R Ahmed; D Zillikens
Journal:  Br J Dermatol       Date:  2001-12       Impact factor: 9.302

2.  Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid.

Authors:  R Neumann; J Tauber; C S Foster
Journal:  Ophthalmology       Date:  1991-06       Impact factor: 12.079

3.  Treatment of pemphigus vulgaris with mycophenolate mofetil.

Authors:  A H Enk; J Knop
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

4.  Cicatricial pemphigoid.

Authors:  A R Ahmed; S M Hombal
Journal:  Int J Dermatol       Date:  1986-03       Impact factor: 2.736

5.  Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.

Authors:  C S Foster; A R Ahmed
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

6.  Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.

Authors:  M Megahed; S Schmiedeberg; J Becker; T Ruzicka
Journal:  J Am Acad Dermatol       Date:  2001-08       Impact factor: 11.527

7.  Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization.

Authors:  S Tyagi; K Bhol; K Natarajan; C Livir-Rallatos; C S Foster; A R Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 8.  Cicatricial pemphigoid.

Authors:  T E Fleming; N J Korman
Journal:  J Am Acad Dermatol       Date:  2000-10       Impact factor: 11.527

9.  Mycophenolate mofetil in autoimmune and inflammatory skin disorders.

Authors:  H C Nousari; A Sragovich; A Kimyai-Asadi; D Orlinsky; G J Anhalt
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

10.  Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.

Authors: 
Journal:  Lancet       Date:  1995-05-27       Impact factor: 79.321

View more
  1 in total

1.  [IgA pemphigus. Successful treatment with mycophenolate mofetil].

Authors:  T Burchardt; A Büchau; T Ruzicka; M Megahed
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.